Celon Pharma SA Financial Flexibility Index
Celon Pharma SA financial flexibility index. Celon Pharma SA (CLN) has a Financial Flexibility Index of 0.07x as of March 2026. Free cash flow of zł9.64 Million (operating CF zł-4.79 Million minus capex zł14.43 Million) represents 0% of total liabilities (zł141.95 Million). Explore CLN capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Celon Pharma SA (2012–2025)
Financial flexibility index of Celon Pharma SA from 2012 to 2025. Historical Financial Flexibility Index trend for Celon Pharma SA across 14 annual periods. Check CLN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Celon Pharma SA Financial Flexibility Index by Year (2012–2025)
Celon Pharma SA financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Celon Pharma SA. For the full cash flow conversion analysis, see cash flow conversion of Celon Pharma SA.
| Year | Flexibility Index | Free Cash Flow (PLN) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.05x | zł78.30 Million | zł23.86 Million | zł74.47 Million | ▲ +805.1% |
| 2024 | 0.12x | zł11.45 Million | zł-11.34 Million | zł98.59 Million | ▼ -41.3% |
| 2023 | 0.20x | zł24.50 Million | zł-8.31 Million | zł123.75 Million | ▼ -12.4% |
| 2022 | 0.23x | zł29.20 Million | zł-4.70 Million | zł129.29 Million | ▼ -59.4% |
| 2021 | 0.56x | zł85.30 Million | zł43.95 Million | zł153.14 Million | ▼ -11.9% |
| 2020 | 0.63x | zł170.07 Million | zł70.90 Million | zł268.97 Million | ▲ +54.4% |
| 2019 | 0.41x | zł59.90 Million | zł-5.05 Million | zł146.31 Million | ▼ -50.8% |
| 2018 | 0.83x | zł95.70 Million | zł28.24 Million | zł114.94 Million | ▲ +25.2% |
| 2017 | 0.66x | zł56.64 Million | zł25.30 Million | zł85.20 Million | ▼ -2.0% |
| 2016 | 0.68x | zł41.93 Million | zł20.65 Million | zł61.82 Million | ▼ -52.9% |
| 2015 | 1.44x | zł97.23 Million | zł52.37 Million | zł67.47 Million | ▲ +10.0% |
| 2014 | 1.31x | zł46.90 Million | zł24.36 Million | zł35.82 Million | ▲ +182.4% |
| 2013 | 0.46x | zł14.09 Million | zł8.45 Million | zł30.39 Million | ▼ -61.7% |
| 2012 | 1.21x | zł17.21 Million | zł12.87 Million | zł14.22 Million | — |